Coverage dated November 15, 2021

Pfizer Signs Deal To Share Its Covid Antiviral Pill With Low Income Nations

Headline from Forbes

The pharmaceutical giant and its development partner Ridgeback Therapeutics signed a licensing deal that will boost access to their new drug.

Forbes's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

7 articles, oldest first.

Forbes
Pfizer Signs Deal To Share Its Covid Antiviral Pill With Low Income Nations (opens Forbes)
Published Nov 15, 2021
Forbes's feed description
The pharmaceutical giant and its development partner Ridgeback Therapeutics signed a licensing deal that will boost access to their new drug.
KVOA Tucson
Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill (opens KVOA Tucson)
Published Nov 15, 2021
KVOA Tucson's feed description
The agreement with the Medicines Patent Pool, a United Nations-backed public health organization, would allow generic manufacturers to make the pill widely available in 95 low- and middle-income countries covering
Breitbart News
Pfizer Announces Licensing Agreement for Its Potential Coronavirus Antiviral Pill (opens Breitbart News)
Published Nov 15, 2021
Breitbart News's feed description
Pfizer on Tuesday announced an agreement allowing other companies to make its potential coronavirus antiviral pill in poorer countries.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.